Myeloid-specific deficiency of group VIA calcium-independent phospholipase A2 preconditions myeloid cells for injury resolution after acetaminophen exposure

IF 6.9 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
Feng Xu , Chutima Jansakun , Gang Li , Uddipta Biswas , Gernot Poschet , Simone Staffer , Sabine Tuma-Kellner , Inaam Nakchbandi , Uta Merle , Walee Chamulitrat
{"title":"Myeloid-specific deficiency of group VIA calcium-independent phospholipase A2 preconditions myeloid cells for injury resolution after acetaminophen exposure","authors":"Feng Xu ,&nbsp;Chutima Jansakun ,&nbsp;Gang Li ,&nbsp;Uddipta Biswas ,&nbsp;Gernot Poschet ,&nbsp;Simone Staffer ,&nbsp;Sabine Tuma-Kellner ,&nbsp;Inaam Nakchbandi ,&nbsp;Uta Merle ,&nbsp;Walee Chamulitrat","doi":"10.1016/j.biopha.2025.118146","DOIUrl":null,"url":null,"abstract":"<div><div>Genetic PLA2G6 variants are associated with C-reactive protein in humans. Myeloid-specific PLA2G6-deficient (Pla2g6<sup>M-/-</sup>) mice show increased hepatic myeloperoxidase and recruitment of granulocytes in response to lipopolysaccharide (LPS). We hypothesized that Pla2g6<sup>M-/-</sup> mice could be protected from acetaminophen (APAP) hepatotoxicity whereby neutrophils, eosinophils, and alternatively activated macrophages are reportedly protective. Herein, Pla2g6<sup>M-/-</sup> mice treated with 300 mg/kg APAP for 24 h showed attenuated hepatic necrosis and plasma cytokines, and with elevated levels of Ly6C<sup>lo</sup> in peripheral blood mononuclear cells and plasma lipoxin A4. Remarkably, bone-marrow-derived macrophages (BMDMs) from untreated Pla2g6<sup>M-/-</sup> mice exhibited elevated baseline expression of cPLA2α, NOX2, Rac1, Arg-1, phospho-MLKL, and iNOS protein, which was exacerbated by LPS <em>in vitro</em>. APAP administration preconditioned Pla2g6<sup>M-/-</sup> BMDMs for further activation of enzymes involving in phagocytosis (Rac1 and phospho-MLKL) and eicosanoids (COX2 and A15LOXB). Pla2g6<sup>M-/-</sup> BMDMs showed an increased release of pro-resolution lipid mediators lipoxin A4, PGE2, and 15d-PGJ2, which was further elevated by LPS <em>in vitro</em> or APAP <em>in vivo</em>. Phagocytic gene signatures (myeloperoxidase and NOX2) were also upregulated in livers of untreated and APAP-treated Pla2g6<sup>M-/-</sup> mice. APAP protection in Pla2g6<sup>M-/-</sup> mice was associated with increased proportion of neutrophils (Ly6G), eosinophils (eosinophilic cationic protein), and M2 macrophages (CD206) in/at the portal tract and central vein as determined by immunohistochemistry. Thus, myeloid-specific PLA2G6 deficiency preconditioned macrophages for eicosanoid and phagocytic pathways rendering protection against APAP hepatotoxicity. Our results may be applicable to patients with PLA2G6 mutations, and PLA2G6 inhibition specifically in myeloid cells may represent a new strategy to alleviate APAP poisoning.</div></div>","PeriodicalId":8966,"journal":{"name":"Biomedicine & Pharmacotherapy","volume":"187 ","pages":"Article 118146"},"PeriodicalIF":6.9000,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedicine & Pharmacotherapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0753332225003403","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Genetic PLA2G6 variants are associated with C-reactive protein in humans. Myeloid-specific PLA2G6-deficient (Pla2g6M-/-) mice show increased hepatic myeloperoxidase and recruitment of granulocytes in response to lipopolysaccharide (LPS). We hypothesized that Pla2g6M-/- mice could be protected from acetaminophen (APAP) hepatotoxicity whereby neutrophils, eosinophils, and alternatively activated macrophages are reportedly protective. Herein, Pla2g6M-/- mice treated with 300 mg/kg APAP for 24 h showed attenuated hepatic necrosis and plasma cytokines, and with elevated levels of Ly6Clo in peripheral blood mononuclear cells and plasma lipoxin A4. Remarkably, bone-marrow-derived macrophages (BMDMs) from untreated Pla2g6M-/- mice exhibited elevated baseline expression of cPLA2α, NOX2, Rac1, Arg-1, phospho-MLKL, and iNOS protein, which was exacerbated by LPS in vitro. APAP administration preconditioned Pla2g6M-/- BMDMs for further activation of enzymes involving in phagocytosis (Rac1 and phospho-MLKL) and eicosanoids (COX2 and A15LOXB). Pla2g6M-/- BMDMs showed an increased release of pro-resolution lipid mediators lipoxin A4, PGE2, and 15d-PGJ2, which was further elevated by LPS in vitro or APAP in vivo. Phagocytic gene signatures (myeloperoxidase and NOX2) were also upregulated in livers of untreated and APAP-treated Pla2g6M-/- mice. APAP protection in Pla2g6M-/- mice was associated with increased proportion of neutrophils (Ly6G), eosinophils (eosinophilic cationic protein), and M2 macrophages (CD206) in/at the portal tract and central vein as determined by immunohistochemistry. Thus, myeloid-specific PLA2G6 deficiency preconditioned macrophages for eicosanoid and phagocytic pathways rendering protection against APAP hepatotoxicity. Our results may be applicable to patients with PLA2G6 mutations, and PLA2G6 inhibition specifically in myeloid cells may represent a new strategy to alleviate APAP poisoning.
对乙酰氨基酚暴露后,髓细胞特异性缺乏钙不依赖磷脂酶A2是髓细胞损伤消退的先决条件
基因PLA2G6变异与人类c反应蛋白有关。髓细胞特异性pla2g6缺陷(Pla2g6M-/-)小鼠对脂多糖(LPS)的反应显示肝髓过氧化物酶和粒细胞的募集增加。我们假设Pla2g6M-/-小鼠可以免受对乙酰氨基酚(APAP)肝毒性的保护,其中中性粒细胞,嗜酸性粒细胞和选择性活化的巨噬细胞据报道具有保护作用。其中,300 mg/kg APAP处理24 h的Pla2g6M-/-小鼠肝坏死和血浆细胞因子减弱,外周血单个核细胞Ly6Clo和血浆脂素A4水平升高。值得注意的是,未经处理的Pla2g6M-/-小鼠骨髓源性巨噬细胞(bmdm) cPLA2α、NOX2、Rac1、Arg-1、phospho-MLKL和iNOS蛋白的基线表达水平升高,体外LPS加剧了这一现象。APAP预处理Pla2g6M-/- BMDMs,进一步激活参与吞噬的酶(Rac1和phospho-MLKL)和类二十烷酸(COX2和A15LOXB)。Pla2g6M-/- BMDMs显示,促分解脂质介质脂素A4、PGE2和15d-PGJ2的释放增加,在体外LPS或体内APAP的作用下进一步升高。在未处理和apap处理的Pla2g6M-/-小鼠的肝脏中,吞噬基因特征(髓过氧化物酶和NOX2)也上调。免疫组化检测显示,APAP对Pla2g6M-/-小鼠的保护作用与门静脉和中央静脉内/处中性粒细胞(Ly6G)、嗜酸性粒细胞(嗜酸性阳离子蛋白)和M2巨噬细胞(CD206)比例增加有关。因此,髓细胞特异性PLA2G6缺乏预先调节巨噬细胞的类二十烷和吞噬途径,从而保护其免受APAP肝毒性。我们的研究结果可能适用于PLA2G6突变患者,而髓细胞特异性抑制PLA2G6可能是缓解APAP中毒的一种新策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
11.90
自引率
2.70%
发文量
1621
审稿时长
48 days
期刊介绍: Biomedicine & Pharmacotherapy stands as a multidisciplinary journal, presenting a spectrum of original research reports, reviews, and communications in the realms of clinical and basic medicine, as well as pharmacology. The journal spans various fields, including Cancer, Nutriceutics, Neurodegenerative, Cardiac, and Infectious Diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信